Loading
No insider purchase over the last 90 days. The latest, by Stockwell Lynn, was filed 01 Oct 2025.
Drugs Made In America Acquisition II Corp. is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Drugs Made In America Acquisition II Corp. The previous disclosure was published on 17 October 2025.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
6 of 6 declarations
Drugs Made In America Acquisition II Corp. is a special purpose acquisition company focused on identifying and acquiring businesses in the pharmaceutical sector. It is listed on NASDAQ.